Skip to content
StockMarketAgent
Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

BOM/524400 stock hub

BOM/524400 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/524400is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
248.2M
Bombay Stock Exchange
Market data

Price

Recent price action with selectable time range.

BOM/524400BOM/524400
Loading chart…
In the news

Latest news · BOM/524400

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E27.9
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC25.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/524400 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
178
Groups with data
10
Currency
INR
Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
14
Employees Change
-3%
Employees Change Percent
-17.65
Enterprise value
INR 161.2M
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Medicinal Chemicals and Botanical Products
Last refreshed
2026-05-10
Market cap
INR 248.2M
Price
INR 83
Price currency
INR
Rev Per Employee
11,548,833.07x
Sic
2833
Symbol
bom/524400
Website
https://www.ishitadrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
3.58%
EV Earnings
18.14x
EV/EBIT
18.88x
EV/EBITDA
16.75x
EV/Sales
1x
P/B ratio
2.21x
P/E ratio
27.95x
P/S ratio
1.54x
PE Ratio10 Y
22.24x
PE Ratio3 Y
29.49x
PE Ratio5 Y
23.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
5.28%
EBITDA Margin
5.95%
Gross margin
16.3%
Gross Profit
INR 26.4M
Gross Profit Growth
-0.79%
Gross Profit Growth Q
-21.09%
Gross Profit Growth3 Y
4.95%
Gross Profit Growth5 Y
5.75%
Net Income
INR 8.9M
Net Income Growth
3.13%
Net Income Growth Q
-34.66%
Net Income Growth3 Y
4.76%
Net Income Growth5 Y
9.93%
Pretax Margin
7.32%
Profit Margin
5.5%
Profit Per Employee
INR 634,993
Roa5y
4.61
Roe5y
8.76
ROIC
25.27
Roic5y
21.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
20.2%
Cagr15y
5.97%
Cagr1y
10.82%
Cagr20y
12.2%
Cagr3y
16.31%
Cagr5y
22.58%
EPS Growth
3.12
EPS Growth Q
-35
EPS Growth3 Y
4.83
EPS Growth5 Y
9.9
Revenue Growth
8.3x
Revenue Growth Q
-24.1x
Revenue Growth3 Y
6.41x
Revenue Growth5 Y
3.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

14
MetricValue
Cash
INR 106.9M
Debt
INR 19.9M
Debt EBITDA
INR 2.07
Debt Equity
INR 0.18
Equity
INR 112.4M
Interest Coverage
18.01
Net Cash
INR 87M
Net Cash By Market Cap
INR 35.04
Net Cash Growth
2.55%
Net Debt EBITDA
INR -9.04
Net Debt Equity
INR -0.77
Tangible Book Value
INR 112.4M
Tangible Book Value Per Share
INR 37.63
WACC
2.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
529.27%
1Y total return
10.81%
200-day SMA
75.34
3Y total return
57.38%
50-day SMA
76.59
50-day SMA vs 200-day SMA
50over200
5Y total return
176.67%
All Time High
104.8
All Time High Change
-20.76%
All Time High Date
2024-08-01
All Time Low
4.91
All Time Low Change
1,590.43%
All Time Low Date
2008-11-21
ATR
5.42
Beta
-0.27
Beta1y
0.06
Beta2y
0.3
Ch YTD
3.75
High
84
High52
90.85
High52 Date
2025-12-29
High52ch
-8.64%
Low
80
Low52
66
Low52 Date
2026-01-13
Low52ch
25.76%
Ma50ch
8.37%
Price vs 200-day SMA
10.17%
RSI
56.3
RSI Monthly
55.42
RSI Weekly
57.11
Sharpe ratio
0.26x
Sortino ratio
0.51
Total Return
-0.02%
Tr YTD
3.75
Tr15y
138.51%
Tr1m
3.05%
Tr1w
5.06%
Tr3m
13.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
INR 8.5M
Operating Income Growth
-5.94
Operating Income Growth Q
-58.77
Operating Income Growth3 Y
-1.63
Operating Income Growth5 Y
5.51
Operating margin
5.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
1,121,770%
Shares Insiders
47.11%
Shares Out
2,990,300
Shares Qo Q
0.17%
Shares Yo Y
0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Average Volume
1,162.8x
Bv Per Share
37.63
Ch10y
529.3
Ch15y
138.5
Ch1m
3.05
Ch1w
5.06
Ch1y
10.81
Ch20y
900
Ch3m
13.73
Ch3y
57.38
Ch5y
176.7
Ch6m
17.7
Change
2.47%
Change From Open
3.75
Close
81
Days Gap
-1.23
Depreciation Amortization
1,084,704
Dollar Volume
490,447
Earnings Date
2026-05-26
EBIT
INR 8.5M
EBITDA
INR 9.6M
EPS
INR 2.97
F Score
1
Fiscal Year End
March
Founded
1,992
Graham Number
50.14884
Graham Upside
-39.58
Income Tax
INR 2.9M
Is Primary Listing
1
Last Earnings Date
2026-02-07
Last Report Date
2025-12-31
Lynch Fair Value
INR 29.48
Lynch Upside
-64.48
Ma150
74.88
Ma150ch
10.85%
Ma20
79.9
Ma20ch
3.88%
Next Earnings Date
2026-05-26
Open
80
Position In Range
75
Price Date
2026-05-08
Price EBITDA
INR 25.79
Ptbv Ratio
2.21
Relative Volume
6.81x
Revenue
161,683,663x
Tax By Revenue
1.82x
Tax Rate
24.89%
Tr20y
900%
Tr6m
17.7%
Volume
5,909
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BOM/524400 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/524400 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+10.8%
S&P 500 1Y: n/a
3Y total return
+57.4%
S&P 500 3Y: n/a
5Y total return
+176.7%
S&P 500 5Y: n/a
10Y total return
+529.3%
S&P 500 10Y: n/a
Ownership

Who owns BOM/524400?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+47.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

BOM/524400 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
56.3
Neutral momentum band
Price vs 200-day MA
+10.2%
50/200-day relationship not available
Beta (5Y)
-0.27
Less volatile than the market
Sharpe ratio
0.26
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/524400

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524400 stock rating?

bom/524400 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524400 analysis?

The full report lives at /stocks/bom/524400/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524400?

The latest report frames bom/524400 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524400 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.